SOPHIA ANTIPOLIS, NICE, France--(BUSINESS WIRE)--Regulatory News: MEDIAN Technologies (Paris: ALMDT)(ALMDT), the leading provider of clinical applications for quantitative management of treatment responses in oncology imaging, announced the introduction on the market of its CTIS product - Clinical Trial Imaging Services.
